(Circulation. 1995;92:3014-3024.)
© 1995 American Heart Association, Inc.
Articles |
Stereoselective Block of Cardiac Sodium Channels by Bupivacaine in Guinea Pig Ventricular Myocytes
From the Institute of Pharmacology and Toxicology, CSIC, School of Medicine, Universidad Complutense, Madrid, Spain (C.V., J.T.); the Departments of Pharmacology and Medicine, Vanderbilt University School of Medicine, Nashville, Tenn (D.J.S., P.B.B.); and the Department of Pharmacology, HPC NV, Oostende, Belgium (L.M.H.).
Correspondence to Carmen Valenzuela, PhD, Institute of Pharmacology and Toxicology, CSIC, School of Medicine, Universidad Complutense, 28040 Madrid, Spain. E-mail carmenva@eucmvx.sim.ucm.es.
Background Bupivacaine is a potent local anesthetic widely used for prolonged local and regional anesthesia. However, accidental intravascular injection of bupivacaine can produce severe arrhythmias and cardiac depression. Although used clinically as a racemic mixture, S(-)-bupivacaine appears less toxic than the R(+)-enantiomer despite at least equal potency for local anesthesia. If the R(+)-enantiomer is more potent in blocking cardiac sodium channels, then the S(-)-enantiomer could be used with less chance of cardiovascular toxicity. Therefore, we tested whether such stereoselectivity existed in the bupivacaine affinity for the cardiac sodium channel.
Methods and Results The inhibitory effects on the cardiac sodium current (INa) of 10 µmol/L R(+)- and S(-)-bupivacaine were investigated by use of the whole-cell voltage clamp technique in isolated guinea pig ventricular myocytes. Both enantiomers produced similar but limited levels of tonic block (6% and 8%). During long depolarizations (5 seconds at 0 mV), R(+)-bupivacaine induced a significantly larger inhibition of INa: 72±2% versus 58±3% for the S(-)-enantiomer (P<.01). Development of block was slow, but its rate was faster for R(+)-bupivacaine [time constant, 1.84±0.16 versus 2.56±0.26 seconds for the S(-)-enantiomer, P<.05]. The voltage dependence of the availability of the Na+ current was shifted to more hyperpolarizing potentials compared with the control; R(+)-bupivacaine induced a larger shift than S(-)-bupivacaine (37±2 versus 30±2 mV, P<.05). These data indicate stereoselective interactions with the inactivated state. In addition, both enantiomers induced substantial use-dependent block during 2.5-Hz pulse trains with medium (100-ms) and short (10-ms) depolarizations but without stereoselective difference. A stepwise approach was used to model these experimental results and to derive apparent affinities and rate constants. We initially assumed that bupivacaine interacted only with the rested and inactivated states of the Na+ channel. The apparent affinities of the inactivated state for S(-)- and R(+)-bupivacaine were 4.8 and 2.9 µmol/L, respectively. With the derived binding and unbinding rate constants, this model reproduced the stereoselective block during long depolarizations but failed to predict the use-dependent block induced by trains of short (10-ms) depolarizations. To account for the observed use-dependent interactions, it was necessary to include interactions with the activated state, which resulted in adequate reproduction of the experimental results. The apparent affinities of the activated or open state for S(-)- and R(+)-bupivacaine were 4.3 and 3.3 µmol/L, respectively.
Conclusions Both the large level of pulse-dependent block and the failure of the pure inactivated-state block model indicate that bupivacaine interacts with the activated (or open) state of the cardiac sodium channel in addition to its block of the inactivated state. The bupivacaine-induced block of the inactivated state of the Na+ channel displayed stereoselectivity, with R(+)-bupivacaine interacting faster and more potently. Both enantiomers also bind with high affinity to the activated or open state of the channel, but this interaction did not display stereoselectivity, although the binding to the activated or open state was faster for S(-)- than for R(+)-bupivacaine. The higher potency of R(+)-bupivacaine to block the inactivated state of the cardiac Na+ channel may explain its higher toxicity because of the large contribution of the inactivated-state block during the plateau phase of the cardiac action potential. These results would support the use of the S(-)-enantiomer to reduce cardiac toxicity.
Key Words: antiarrhythmia agents • electrophysiology • receptors • pharmacology • sodium
This article has been cited by other articles:
 |
|
 |
|
  N. G. B. Chedid, R. T. Sudo, M. I. S. Aguiar, M. M. Trachez, M. O. Masuda, and G. Zapata-Sudo Regulation of intracellular calcium by bupivacaine isomers in cardiac myocytes from wistar rats. Anesth. Analg., March 1, 2006; 102(3): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ulbricht Sodium Channel Inactivation: Molecular Determinants and Modulation Physiol Rev, October 1, 2005; 85(4): 1271 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Wang, C. Russell, and S.-Y. Wang Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels J. Physiol., February 1, 2004; 554(3): 621 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Urbanek, A. Duma, O. Kimberger, G. Huber, P. Marhofer, M. Zimpfer, and S. Kapral Onset Time, Quality of Blockade, and Duration of Three-in-One Blocks with Levobupivacaine and Bupivacaine Anesth. Analg., September 1, 2003; 97(3): 888 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Wang, C. Russell, and S.-Y. Wang State-dependent Block of Wild-type and Inactivation-deficient Na+ Channels by Flecainide J. Gen. Physiol., August 25, 2003; 122(3): 365 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Kindler, M. Paul, H. Zou, C. Liu, B. D. Winegar, A. T. Gray, and C. S. Yost Amide Local Anesthetics Potently Inhibit the Human Tandem Pore Domain Background K+ Channel TASK-2 (KCNK5) J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 84 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Crews and T. E. Rothman Seizure After Levobupivacaine for Interscalene Brachial Plexus Block Anesth. Analg., April 1, 2003; 96(4): 1188 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.F. Starmer, A.O. Grant, and T.J. Colatsky What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs Cardiovasc Res, March 15, 2003; 57(4): 1062 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Choe, Y.-K. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, C.-U. Joo, M.-H. Kim, G.-S. Kim, J.-S. Eun, J.-H. Kim, et al. Papaverine Blocks hKv1.5 Channel Current and Human Atrial Ultrarapid Delayed Rectifier K+ Currents J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 706 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Crews, R. S. Weller, J. Moss, and R. L. James Levobupivacaine for Axillary Brachial Plexus Block: A Pharmacokinetic and Clinical Comparison in Patients with Normal Renal Function or Renal Disease Anesth. Analg., July 1, 2002; 95(1): 219 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Pouzeratte, J. M. Delay, G. Brunat, G. Boccara, C. Vergne, S. Jaber, J. M. Fabre, P. Colson, and C. Mann Patient-Controlled Epidural Analgesia After Abdominal Surgery: Ropivacaine Versus Bupivacaine Anesth. Analg., December 1, 2001; 93(6): 1587 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Lefrant, J. E. de La Coussaye, J. Ripart, L. Muller, L. Lalourcey, P. A. Peray, X. Mazoit, A. Sassine, and J.-J. Eledjam The Comparative Electrophysiologic and Hemodynamic Effects of a Large Dose of Ropivacaine and Bupivacaine in Anesthetized and Ventilated Piglets Anesth. Analg., December 1, 2001; 93(6): 1598 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. González, M. Longobardo, R. Caballero, E. Delpón, J. Tamargo, and C. Valenzuela Effects of Bupivacaine and a Novel Local Anesthetic, IQB-9302, on Human Cardiac K+ Channels J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 573 - 583. [Abstract] [Full Text]
|
|
|
|
|
|
G. Zapata-Sudo, M. M. Trachez, R. T. Sudo, and T. E. Nelson Is Comparative Cardiotoxicity of S(-) and R(+) Bupivacaine Related to Enantiomer-Selective Inhibition of L-Type Ca2+ Channels? Anesth. Analg., February 1, 2001; 92(2): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Groban, D. D. Deal, J. C. Vernon, R. L. James, and J. Butterworth Cardiac Resuscitation After Incremental Overdosage with Lidocaine, Bupivacaine, Levobupivacaine, and Ropivacaine in Anesthetized Dogs Anesth. Analg., January 1, 2001; 92(1): 37 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Brau, P. Branitzki, A. Olschewski, W. Vogel, and G. Hempelmann Block of Neuronal Tetrodotoxin-Resistant Na+ Currents by Stereoisomers of Piperidine Local Anesthetics Anesth. Analg., December 1, 2000; 91(6): 1499 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Groban, D. D. Deal, J. C. Vernon, R. L. James, and J. Butterworth Ventricular Arrhythmias With or Without Programmed Electrical Stimulation After Incremental Overdosage with Lidocaine, Bupivacaine, Levobupivacaine, and Ropivacaine Anesth. Analg., October 1, 2000; 91(5): 1103 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. McCaslin and J. Butterworth Bupivacaine Suppresses [Ca2+]i Oscillations in Neonatal Rat Cardiomyocytes with Increased Extracellular K+ and Is Reversed with Increased Extracellular Mg2+ Anesth. Analg., July 1, 2000; 91(1): 82 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Morrison, J. J. Dominguez, P. Frascarolo, and S. Reiz A Comparison of the Electrocardiographic Cardiotoxic Effects of Racemic Bupivacaine, Levobupivacaine, and Ropivacaine in Anesthetized Swine Anesth. Analg., June 1, 2000; 90(6): 1308 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nau, M. Seaver, S.-Y. Wang, and G. K. Wang Block of Human Heart hH1 Sodium Channels by Amitriptyline J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1015 - 1023. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Crews, A. H. Hord, D. D. Denson, and C. Schatzman A Comparison of the Analgesic Efficacy of 0.25% Levobupivacaine Combined with 0.005% Morphine, 0.25% Levobupivacaine Alone, or 0.005% Morphine Alone for the Management of Postoperative Pain in Patients Undergoing Major Abdominal Surgery Anesth. Analg., December 1, 1999; 89(6): 1504 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Nau, S.-Y. Wang, G. R. Strichartz, and G. K. Wang Point Mutations at N434 in D1-S6 of {micro}1 Na+ Channels Modulate Binding Affinity and Stereoselectivity of Local Anesthetic Enantiomers Mol. Pharmacol., August 1, 1999; 56(2): 404 - 413. [Abstract] [Full Text]
|
|
|
|
|
|
M. Longobardo, E. Delpón, R. Caballero, J. Tamargo, and C. Valenzuela Structural Determinants of Potency and Stereoselective Block of hKv1.5 Channels Induced by Local Anesthetics Mol. Pharmacol., July 1, 1998; 54(1): 162 - 169. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Franqueza, M. Longobardo, J. Vicente, E. Delpon, M. M. Tamkun, J. Tamargo, D. J. Snyders, and C. Valenzuela Molecular Determinants of Stereoselective Bupivacaine Block of hKv1.5 Channels Circ. Res., December 19, 1997; 81(6): 1053 - 1064. [Abstract] [Full Text]
|
|
|
|
|
|
R. E. Joseph Jr., W.-J. Tsai, L.-I Tsao, T.-P. Su, and E. J. Cone In Vitro Characterization of Cocaine Binding Sites in Human Hair J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1228 - 1241. [Abstract] [Full Text]
|
|